Vitamin D metabolites and risk of first clinical diagnosis of central nervous system demyelination

Vitamin D metabolites and risk of first clinical diagnosis of central nervous system demyelination

Low 25-hydroxyvitamin D (25(OH)D) concentration is a recognised risk factor for multiple sclerosis (MS). Associations with vitamin D metabolites and vitamin D binding globulin (VDBG) have not been widely studied. We assessed the association between vitamin D metabolites (25(OH)D2, 25(OH)D3, c3-epime...

Full description

Bibliographic Details
Main Authors: Tiller, C., Black, Lucinda, Ponsonby, A.L., Taylor, B., van der Mei, I., Clarke, M.W., Lucas, R.M.
Format: Journal Article
Language:English
Published: PERGAMON-ELSEVIER SCIENCE LTD 2022
Subjects:
Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Endocrinology & Metabolism
Multiple sclerosis
Vitamin D
Free vitamin D
Vitamin D binding protein
First demyelinating event
D-BINDING PROTEIN
MULTIPLE-SCLEROSIS
25-HYDROXYVITAMIN D
ENVIRONMENT
ADULTS
RATIO
Online Access:http://hdl.handle.net/20.500.11937/90046

Internet

http://hdl.handle.net/20.500.11937/90046

Similar Items